Recombinant Human Von Hippel Lindau Tumor Suppressor (vHL), Unconjugated, E. coli

Catalog Number: BIM-RPU56239
Article Name: Recombinant Human Von Hippel Lindau Tumor Suppressor (vHL), Unconjugated, E. coli
Biozol Catalog Number: BIM-RPU56239
Supplier Catalog Number: RPU56239
Alternative Catalog Number: BIM-RPU56239-50UG,BIM-RPU56239-100UG,BIM-RPU56239-1MG
Manufacturer: Biomatik Corporation
Host: E. coli
Category: Proteine/Peptide
Application: Control, SDS-PAGE, WB
Species Reactivity: Human
Conjugation: Unconjugated
Alternative Names: HRCA1, RCA1, VHL1, Von Hippel-Lindau Syndrome
Recombinant Human Von Hippel Lindau Tumor Suppressor (vHL) is a purified Prokaryotic Protein. Purity: >80% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Von Hippel Lindau Tumor Suppressor (vHL). Target Synonyms: HRCA1, RCA1, VHL1, Von Hippel-Lindau Syndrome. Accession Number: P40337. Gene ID: 7428. Expression Region: Met1~Asp213. Tag Info: N-terminal His Tag. Theoretical MW: 35kDa. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Molecular Weight: 35kDa
Tag: N-Terminal His Tag
NCBI: 7428
Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Expression System: Prokaryotic Expression
Purity: >80% by SDS-PAGE
Form: Freeze-dried powder
Target: Von Hippel Lindau Tumor Suppressor (vHL)